The biologic dosed every 2 weeks reduced moderate or severe COPD exacerbations over 52 weeks by a relative 15.4% compared ...

We recently compiled a list of the 12 Best Performing Healthcare Stocks to Buy Right Now. Verona Pharma plc is one of them.

Christopher Carlin, MBChB, PhD, explores the potential of AI-driven insights to enhance COPD care and identify candidates for biologic therapy.

Biological therapy was associated with significant changes in lung structure and, by extension, improved lung function in individuals with chronic obstructive pulmonary disease ( COPD) and T2 ...

Dr. Rojas-Quintero is researching how Metformin, a long-used diabetes drug, may be able to slow fibrosis in the lungs.

A new Northwestern Medicine study is challenging long-held assumptions about chronic obstructive pulmonary disease (COPD), ...

The disappointing result means that AZ will be unable to follow in the footsteps of GSK, whose IL-5 inhibitor Nucala ...

Experts at European Respiratory Society (ERS) Congress 2025 highlight the critical link between reduced lung function and ...

OSA and COPD present with symptoms that often go undetected for too long. How can clinicians recognize symptoms faster?

An EHR-embedded inpatient care pathway for COPD was tied to improved adherence to evidence-based practices, shorter hospital ...

Chronic respiratory diseases are among the top causes of death and disability worldwide, yet receive little political or ...

Congress demonstrated that just under 50% of people assessed through the FRONTIER Hull Programme were diagnosed with chronic obstructive pulmonary disease (COPD) following a previous assessment via ...